Biocodex, a global pharmaceutical company and long-time pioneer in the treatment of rare pediatric diseases, will present 12 studies at the upcoming AES 2025 Annual Meeting in Atlanta, Georgia, ...
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start of therapy ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
The role of biomechanical cues in the progression of PM2.5-induced corneal disease was investigated, and PAI-2 was identified ...
Introduction Alcohol is consumed by an estimated 137.4 million people in the USA 12 years of age and older and, as a result, ...
Mast cell activation syndrome is a condition that causes mast cells to release an inappropriate amount of chemicals into your body. This causes allergy symptoms and a wide range of other symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback